AI Verdict
MRK has stronger fundamentals based on our AI analysis.
ABT vs MRK Fundamental Comparison
| Metric | ABT | MRK |
|---|---|---|
| Revenue | $11.2B | $16.3B |
| Net Income | $1.1B | $-4.2B |
| Net Margin | 9.6% | -26.0% |
| ROE | 2.1% | -9.2% |
| ROA | 1.0% | -3.3% |
| Current Ratio | 1.39x | 1.30x |
| Debt/Equity | 0.57x | 1.02x |
| EPS | $0.61 | $-1.72 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABT vs MRK: Frequently Asked Questions
Is ABT or MRK a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MRK has stronger fundamentals. ABT is rated HOLD (74% confidence) while MRK is rated HOLD (78% confidence). This is not investment advice.
How does ABT compare to MRK fundamentally?
ABBOTT LABORATORIES has ROE of 2.1% vs Merck & Co., Inc.'s -9.2%. Net margins are 9.6% vs -26.0% respectively.
Which stock pays higher dividends, ABT or MRK?
ABT has a dividend yield of N/A or no dividend while MRK has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABT or MRK for long term?
For long-term investing, consider that ABT has HOLD rating with 74% confidence, while MRK has HOLD rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABT vs MRK?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABT vs MRK, the AI consensus favors MRK based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.